Introduction Anxiety and depression were known to bring detrimental outcome in patients
with ischemic heart disease (IHD). Notwithstanding their high prevalence
and catastrophic impact, anxiety and depression were unrecognized and
untreated. The aim of this study was to determine the prevalence of anxiety
and depression among IHD patients and the association of this condition with
clinical and selected demographic factors.
Methods This was a cross-sectional study on 100 IHD patients admitted to medical
ward in UKMMC. Patients diagnosed to have IHD were randomly assessed
using Hospital Anxiety and Depression Scale (HADS) and Perceived Social
Support (PSS) Questionnaire. Socio-demographic data were obtained by
direct interview. Fifteen percent of IHD patients in this sample were noted to
have anxiety, fourteen percent noted to have depression while thirty two
percent was noted to have both anxiety and depression. Patients’ age group
and the duration of illness were found to have significant association with
anxiety. Socio-demographic data were obtained by direct interview.
Results Fifteen percent of IHD patients in this sample were noted to have anxiety,
fourteen percent noted to have depression while thirty two percent was noted
to have both anxiety and depression. Patients’ age group and the duration of
illness were found to have significant association with anxiety. The other
clinical and selected demographic factors such as gender, race, marital status,
education level, occupation, co-existing medical illness and social support
were not found to be significantly associated with anxiety or depression
among the IHD patients.
Conclusions In conclusion, proper assessment of anxiety and depression in IHD patients,
with special attention to patients’ age and duration of illness should be
carried out routinely to help avert detrimental consequences.
Thoracic or abdominal chylous leakage, a rare complication of lymph node removal procedures, can lead to the accumulation of lymph fluid within the abdominal cavity, resulting in chylous ascites, abdominal distension, discomfort, and an increased risk of infection. Lipiodol lymphangiography, a diagnostic procedure utilizing a unique contrast agent, serves to identify the site and cause of chylous leaks. Furthermore, it functions as a therapeutic tool by injecting Lipiodol into the affected lymphatic vessel. By employing this diagnostic procedure, successful closure of the leak can be achieved. We present a case where a chylous leak was effectively treated with Lipiodol injection following the robotic-assisted removal of metastatic lymph nodes surgery.